EFG Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Buy |
22,878
+5,507
| +32% | +$757K | 0.44% | 98 |
|
|
2025
Q1 | $3.13M | Sell |
17,371
-343
| -2% | -$61.8K | 0.52% | 65 |
|
|
2024
Q4 | $2.78M | Buy |
17,714
+4,185
| +31% | +$656K | 0.38% | 111 |
|
|
2024
Q3 | $2.46M | Buy |
13,529
+974
| +8% | +$177K | 0.41% | 101 |
|
|
2024
Q2 | $2.31M | Buy |
12,555
+60
| +0.5% | +$11K | 0.4% | 95 |
|
|
2024
Q1 | $2.22M | Buy |
12,495
+2,299
| +23% | +$409K | 0.38% | 103 |
|
|
2023
Q4 | $1.26M | Sell |
10,196
-6,038
| -37% | -$749K | 0.24% | 154 |
|
|
2023
Q3 | $1.88M | Sell |
16,234
-1,550
| -9% | -$180K | 0.45% | 73 |
|
|
2023
Q2 | $2.09M | Sell |
17,784
-3,065
| -15% | -$360K | 0.45% | 70 |
|
|
2023
Q1 | $1.67M | Sell |
20,849
-1,167
| -5% | -$93.5K | 0.37% | 94 |
|
|
2022
Q4 | $1.76M | Buy |
22,016
+4,315
| +24% | +$345K | 0.4% | 90 |
|
|
2022
Q3 | $1.23M | Buy |
+17,701
| New | +$1.23M | 0.28% | 118 |
|